Medical Devices; Radiology Devices; Classification of the Phase-Changing Fiducial Marker for Radiation Therapy
The Food and Drug Administration (FDA) is classifying the phase-changing fiducial marker for radiati...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Federal Register
- Region
- USA
- Scope
- Regulatory
- Published
- July 29, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The Food and Drug Administration (FDA) is classifying the phase-changing fiducial marker for radiati...
Source route
Continue on federalregister.gov
Leave the platform to read the original full article on the publisher site.
Source: Federal Register
Scope: Regulatory
Related coverage
More related coverage
Drug label update: Cefpodoxime Proxetil
Official structured record identifier: 8519a9d8-7106-4545-bc58-859ee9a6708e.
Respiratory syncytial virus (RSV) maternal vaccination coverage in England: March 2026
Insights on the vaccine uptake and commentary on the RSV (respiratory syncytial virus) vaccination p...
Respiratory syncytial virus (RSV) older adults vaccination coverage in England: June 2026
Insights on the vaccine uptake and commentary on the RSV (respiratory syncytial virus) vaccination p...
Vaccine update: issue 373, July 2026
Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.